Tumour

The cancer survival rate has barely changed over the last 20 years, despite the constant appearance of new treatments. Time and time again, medicines are launched which are later proven to be counter-productive.

This shows us that a rethink is needed, a new understanding, on what the disease is dependent. Evomed combines new scientific findings with established and innovative diagnosis and treatment methods in order to be able to understand the disease better and to open new treatment possibilities.

An important approach: energy production of the tumour cells

Thanks to new developments in cancer research, it is now possible to identify two different types of cancer cells in a tumour - irrespective of the affected organs. The two types are "glucose burning" (TKTL1 negative) cells and "fermenting" (TKTL1-positive) cells.

The "fermenting" cells are the most threatening for cancer patients:

They encourage metastasis and therefore the spread of the cancer within the body.

At the same time they have proven to be resistant to chemotherapy and radiotherapy.

Both is caused by the special tumour cell metabolism.

The existence of "fermenting" cells is determined reliably by a simple blood test. The EDIM-TKTL1-Bloodtest detects high concentrations of TKTL1 in the blood. TKTL1 is the enzyme which the "fermenting" cells need in order to produce energy.

Currently there exists no medical treatment targeted at TKTL1-positive cancer cells. However, with a special diet (the Coy principle), it is possible to do something about this type of cell’s energy production..

Find out more at www.tavarlin.de.